Nanjing King-Friend Biochemical Pharmaceutical Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LONN | Lonza Group | Buy |
16
|
CHF529.20 | CHF516.89 | 13.38% | 8 | CHF38.16B |
| 603259 | WuXi AppTec | Buy |
18
|
¥44.90 | ¥121.48 | 41.16% | 0 | ¥127.92B |
| 000963 | Huadong Medicine | Buy |
18
|
¥33.25 | ¥52.40 | 33.08% | 3 | ¥59.08B |
| 000513 | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | ¥39.23 | 11.41% | 0 | ¥28.75B |
| 603456 | Zhejiang Jiuzhou Pharmaceutica... | Buy |
18
|
¥15.92 | ¥37.79 | 48.30% | 0 | ¥14.50B |